UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in RVMD — Revolution Medicines, Inc.

CIK 861177 NEW YORK, NY

Back to RVMD Full portfolio

Position in RVMD

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$48,682,860

+$20,852,198 QoQ

Shares Held

500,595

+43.3% QoQ

Ownership

0.235%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

23 quarters on record

Voting authority Sole 43.22036776236279.ToString("F0")% Shared 0.ToString("F0")% None 56.77963223763721.ToString("F0")%

Common Shares in RVMD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. RVMD ranks #15 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,057,396	$1,365,249,602
2	REGN	Regeneron Pharmaceuticals, Inc.	723,621	$559,098,523
3	ALNY	Alnylam Pharmaceuticals, Inc.	677,519	$224,170,706
4	INSM	INSMED Inc	1,215,025	$198,680,883
5	RPRX	Royalty Pharma plc	3,095,766	$148,503,890
6	INCY	Incyte Corp	1,540,913	$145,030,725
7	IONS	Ionis Pharmaceuticals Inc	1,475,632	$110,805,201
8	DNLI	Denali Therapeutics Inc.	4,432,314	$85,100,425

All Filings in RVMD

Export CSV

23 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$48,682,860	500,595	+43.3%	Shares	Defined	2026-05-13
2025-12-31	$27,830,662	349,412	+2.4%	Shares	Defined	2026-02-13
2025-09-30	$15,941,835	341,367	-31.8%	Shares	Sole	2025-11-14
2025-06-30	$18,420,638	500,697	+66.8%	Shares	Defined	2025-08-14
2025-03-31	$10,614,928	300,196	+14.2%	Shares	Defined	2025-05-19
2024-12-31	$11,497,099	262,851	+21.7%	Shares	Defined	2025-02-14
2024-09-30	$9,796,776	216,026	-10.5%	Shares	Defined	2024-11-14
2024-06-30	$9,370,555	241,447	+81.3%	Shares	Defined	2024-08-14
2024-03-31	$4,292,196	133,174	0.0%	Shares	Defined	2024-05-15
2023-12-31	$3,819,429	133,174	+27.8%	Shares	Defined	2024-02-14
2023-09-30	$2,885,306	104,238	+15.4%	Shares	Defined	2023-11-13
2023-06-30	$2,416,192	90,325	0.0%	Shares	Defined	2023-08-11
2023-03-31	$1,956,437	90,325	+43.6%	Shares	Defined	2023-05-15
2022-12-31	$1,498,300	62,901	+43.0%	Shares	Sole	2023-02-14
2022-09-30	$867,501	43,991	+1.1%	Shares	Sole	2022-11-14
2022-06-30	$848,397	43,530	-24.3%	Shares	Sole	2022-08-12
2022-03-31	$1,467,794	57,538	+41.0%	Shares	Defined	2022-05-16
2021-12-31	$1,027,287	40,814	+5.1%	Shares	Defined	2022-02-14
2021-09-30	$1,068,266	38,832	+1.0%	Shares	Defined	2021-11-15
2021-06-30	$1,220,719	38,460	+72.5%	Shares	Defined	2021-08-16
2021-03-31	$1,023,124	22,300	-10.2%	Shares	Defined	2021-05-14
2020-12-31	$982,980	24,829	+249.7%	Shares	Defined	2021-03-01
2020-09-30	$247,080	7,100	—	Shares	Defined	2020-11-13
No filing history on record for this holder in this stock.